Seer, Inc.
SEERSeer, Inc. in brief
Seer, Inc. is a listed company in the Biotechnology industry, based in Redwood City, California, USA. It was founded in 2017. Its market value was $115 M on 1 August 2026, which makes it the 18,232nd largest listed company in the world and the 3,450th largest in the USA on this site. In the year to December 2025 it had sales of $17 M and a net loss of $74 M. It employs about 60 people and Omid Cameron Farokhzad is its chief executive. Its shares trade under the symbol SEER (Nasdaq).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Seer, Inc.
Seer Inc is a biotechnology sector company that develop innovative solutions that act as a gateway to the proteome. The headquarters is in USA.
The Seer approach combines proprietary engineered nanoparticles with an automated assay solution to provide an unmatched combination of unbiased, deep, rapid, and scalable workflow to give you a clearer view of the proteome.
The company annual net income is 16.0 million USD, annual revenue is 1.07 billion USD and 60 employees as on 2019. The headquarters is in USA.
Seer, Inc. timeline
- 2017
- 🏁
- 2018
- ✎Renamed Seer, Inc.Formerly Seer Biosciences, Inc..
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- 2020
- 🔔Initial public offering on Nasdaq as SEERFinal prospectus filed with the SEC on 4 December 2020; shares registered for exchange trading on 30 November 2020.
- 2023
- 💰Record revenue of $17 millionFY2023, the highest of the 6 years on record.
Events of Seer, Inc. from Wikidata, SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in USA: #1,288 (Jan 2021) · #2,423 (Jan 2022) · #3,005 (Dec 2022) · #3,152 (Jul 2023) · #3,572 (Jan 2024) · #1,920 (Mar 2026) · #3,365 (Aug 2026)
Key ratios
- P/E ratio (TTM)
- n/m (loss)
- Price / sales (TTM)
- 8.2×
- Price / book
- 0.4×
- Free cash flow yield
- -40.2%
- Net margin (TTM)
- -450.9%
- Operating margin
- -470.4%
- Return on equity
- -24.5%
- Liabilities / assets
- 12.4%
- Revenue growth
- +17.0%
- R&D / revenue
- 264.6%
- Revenue per employee
- $276 K
- Profit per employee
- $-1.2 M
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $17M | +17.0% | $-78M | $-74M | -443.9% |
| Dec 2024 | $14M | -14.9% | $-100M | $-87M | -611.2% |
| Dec 2023 | $17M | +7.6% | $-103M | $-86M | -517.9% |
| Dec 2022 | $15M | +134.0% | $-97M | $-93M | -600.2% |
| Dec 2021 | $7M | +903.0% | $-71M | $-71M | -1075.1% |
| Dec 2020 | $1M | — | $-34M | $-33M | -4966.7% |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Dec 2025 | $-44M | $2M | $-46M | — | $0.00 |
| Dec 2024 | $-46M | $4M | $-50M | — | $0.00 |
| Dec 2023 | $-59M | $7M | $-66M | $-1.35 | $0.00 |
| Dec 2022 | $-61M | $10M | $-71M | $-1.49 | — |
| Dec 2021 | $-46M | $7M | $-53M | $-1.17 | — |
| Dec 2020 | $-21M | $5M | $-25M | $-2.48 | — |
Quarterly results
Latest quarter to Sep 2026: revenue $4M (-3.4% on a year earlier), net income $-14M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.
SEC filings
- Nov 10, 202610-QQuarterly report · period to Sep 2026
- Nov 10, 20268-KCurrent reportResults of operations
- Oct 29, 20268-KCurrent reportOther events
- Sep 18, 20268-KCurrent reportDirectors or officers changed
- Aug 11, 202610-QQuarterly report · period to Jun 2026
- Aug 11, 20268-KCurrent reportResults of operations
- Jul 31, 20268-KCurrent reportShareholder vote
- Jul 31, 20268-KCurrent reportOther events
- Jul 20, 20268-KCurrent reportOther events
- Jul 2, 20268-KCurrent reportOther events
- May 22, 20268-KCurrent reportOther events
- May 13, 202610-QQuarterly report · period to Mar 2026
Official filings of Seer, Inc. with the US Securities and Exchange Commission.
Annual results
- Revenue
- $17 M
- Operating income
- $-78 M
- Net income
- $-74 M
For year ending December-2025 · source: SEC filing
Balance sheet
- Total assets
- $296 M
- Total liabilities
- $37 M
- Total equity
- $259 M
As of December-2025
Top 68 institutional investors in Seer, Inc.#
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 1 | Softbank Group Corp. | 5,135,383 | 0 (0.00%) | 9.20% | $11 M | Nov 16, 2026 |
| 2 | BML Capital Management, LLC | 2,186,587 | New | 3.92% | $5 M | Nov 6, 2026 |
| 3 | Acadian Asset Management LLC | 1,953,704 | 0 (0.00%) | 3.50% | $4 M | Nov 9, 2026 |
| 4 | Vanguard Capital Management LLC | 1,784,650 | -46,408 (-2.53%) | 3.20% | $4 M | Nov 13, 2026 |
| 5 | BlackRock, Inc. | 1,368,256 | -60,149 (-4.21%) | 2.45% | $3 M | Nov 13, 2026 |
| 6 | Renaissance Technologies LLC | 987,600 | +2,100 (+0.21%) | 1.77% | $2 M | Nov 12, 2026 |
| 7 | Two Sigma Investments, LP | 916,470 | +424,172 (+86.16%) | 1.64% | $2 M | Nov 16, 2026 |
| 8 | Nano Cap New Millennium Growth Fund L P | 700,000 | -125,000 (-15.15%) | 1.25% | $2 M | Nov 13, 2026 |
| 9 | Bridgeway Capital Management, LLC | 508,323 | +48,880 (+10.64%) | 0.91% | $1 M | Nov 16, 2026 |
| 10 | Rangeley Capital, LLC | 504,588 | +282,588 (+127.29%) | 0.90% | $1 M | Nov 16, 2026 |
| 11 | Geode Capital Management, LLC | 491,128 | +30,698 (+6.67%) | 0.88% | $1 M | Nov 6, 2026 |
| 12 | Peapod Lane Capital LLC | 421,484 | -23,966 (-5.38%) | 0.76% | $1 M | Oct 22, 2026 |
| 13 | 1888 Investments, LLC | 359,143 | 0 (0.00%) | 0.64% | $1 M | Nov 4, 2026 |
| 14 | Advisory Services Network, LLC | 329,600 | +186,952 (+131.06%) | 0.59% | $1 M | Nov 13, 2026 |
| 15 | Vanguard Fiduciary Trust Co | 281,849 | +64,888 (+29.91%) | 0.51% | $1 M | Nov 13, 2026 |
| 16 | Citadel Advisors LLC | 263,600 | -255,710 (-49.24%) | 0.47% | $1 M | Nov 16, 2026 |
| 17 | Goldman Sachs Group Inc | 255,506 | +8,868 (+3.60%) | 0.46% | $1 M | Nov 16, 2026 |
| 18 | Dimensional Fund Advisors LP | 212,625 | 0 (0.00%) | 0.38% | $0 M | Nov 4, 2026 |
| 19 | Shay Capital LLC | 200,772 | +106,564 (+113.12%) | 0.36% | $0 M | Nov 16, 2026 |
| 20 | Edgewood Management LLC | 200,000 | 0 (0.00%) | 0.36% | $0 M | Nov 12, 2026 |
| 21 | Jane Street Group, LLC | 174,047 | +114,647 (+193.01%) | 0.31% | $0 M | Nov 12, 2026 |
| 22 | State Street Corp | 159,950 | 0 (0.00%) | 0.29% | $0 M | Nov 12, 2026 |
| 23 | Gsa Capital Partners LLP | 159,603 | -24,921 (-13.51%) | 0.29% | $0 M | Nov 16, 2026 |
| 24 | Squarepoint Ops LLC | 155,533 | New | 0.28% | $0 M | Nov 9, 2026 |
| 25 | Marshall Wace, LLP | 153,943 | New | 0.28% | $0 M | Nov 13, 2026 |
Show all 68: investors 26 to 68
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 26 | Morgan Stanley | 145,664 | +230 (+0.16%) | 0.26% | $0 M | Nov 13, 2026 |
| 27 | Susquehanna International Group, LLP | 141,199 | New | 0.25% | $0 M | Nov 16, 2026 |
| 28 | Jacobs Levy Equity Management, Inc | 121,818 | -100,514 (-45.21%) | 0.22% | $0 M | Nov 16, 2026 |
| 29 | HSBC Holdings PLC | 112,584 | -1,764 (-1.54%) | 0.20% | $0 M | Nov 16, 2026 |
| 30 | Wittenberg Investment Management, Inc. | 81,989 | New | 0.15% | $0 M | Nov 16, 2026 |
| 31 | Northern Trust Corp | 78,876 | -19 (-0.02%) | 0.14% | $0 M | Nov 16, 2026 |
| 32 | American Century Companies Inc | 73,815 | 0 (0.00%) | 0.13% | $0 M | Nov 12, 2026 |
| 33 | Corient Private Wealth LP | 73,200 | 0 (0.00%) | 0.13% | $0 M | Nov 16, 2026 |
| 34 | Royal Bank Of Canada | 71,558 | -2 (0.00%) | 0.13% | $0 M | Nov 16, 2026 |
| 35 | Palumbo Wealth Management LLC | 69,904 | +1,421 (+2.07%) | 0.13% | $0 M | Nov 13, 2026 |
| 36 | Empowered Funds, LLC | 65,580 | New | 0.12% | $0 M | Nov 13, 2026 |
| 37 | Bank Of America Corp /de/ | 57,070 | +77 (+0.14%) | 0.10% | $0 M | Nov 16, 2026 |
| 38 | Price T Rowe Associates Inc /MD/ | 51,914 | 0 (0.00%) | 0.09% | $0 M | Nov 16, 2026 |
| 39 | Covestor Ltd | 49,078 | New | 0.09% | $0 M | Oct 30, 2026 |
| 40 | Allworth Financial LP | 40,985 | New | 0.07% | $0 M | Nov 17, 2026 |
| 41 | Schonfeld Strategic Advisors LLC | 39,440 | New | 0.07% | $0 M | Nov 16, 2026 |
| 42 | XTX Topco Ltd | 36,895 | -7,482 (-16.86%) | 0.07% | $0 M | Nov 16, 2026 |
| 43 | Arrowstreet Capital, Limited Partnership | 27,756 | New | 0.05% | $0 M | Nov 13, 2026 |
| 44 | Pathstone Holdings, LLC | 26,510 | 0 (0.00%) | 0.05% | $0 M | Nov 13, 2026 |
| 45 | Invesco Ltd. | 23,210 | -625 (-2.62%) | 0.04% | $0 M | Nov 12, 2026 |
| 46 | Tower Research Capital LLC (TRC) | 20,639 | +20,008 (+3170.84%) | 0.04% | $0 M | Nov 16, 2026 |
| 47 | Axq Capital, LP | 19,316 | New | 0.03% | $0 M | Nov 12, 2026 |
| 48 | Point72 Asset Management, L.P. | 18,921 | +4,806 (+34.05%) | 0.03% | $0 M | Nov 16, 2026 |
| 49 | Connor, Clark & Lunn Investment Management Ltd. | 16,852 | New | 0.03% | $0 M | Nov 10, 2026 |
| 50 | Sequoia Financial Advisors, LLC | 16,600 | 0 (0.00%) | 0.03% | $0 M | Nov 13, 2026 |
| 51 | Spark Investment Management LLC | 16,100 | New | 0.03% | $0 M | Nov 13, 2026 |
| 52 | FNY Investment Advisers, LLC | 15,590 | +7,090 (+83.41%) | 0.03% | $0 M | Oct 16, 2026 |
| 53 | Bronte Capital Management Pty Ltd. | 15,109 | 0 (0.00%) | 0.03% | $0 M | Nov 12, 2026 |
| 54 | GTS Securities LLC | 15,002 | New | 0.03% | $0 M | Nov 16, 2026 |
| 55 | Barclays PLC | 13,128 | +5,001 (+61.54%) | 0.02% | $0 M | Nov 6, 2026 |
| 56 | Vanguard Global Advisers, LLC | 12,889 | 0 (0.00%) | 0.02% | $0 M | Nov 13, 2026 |
| 57 | StoneX Group Inc. | 10,575 | New | 0.02% | $0 M | Nov 3, 2026 |
| 58 | UBS Group AG | 5,909 | -20,230 (-77.39%) | 0.01% | $0 M | Nov 10, 2026 |
| 59 | Jpmorgan Chase & Co | 2,465 | +2,331 (+1739.55%) | 0.00% | $0 M | Nov 12, 2026 |
| 60 | SBI Securities Co., Ltd. | 2,068 | -268 (-11.47%) | 0.00% | $0 M | Oct 22, 2026 |
| 61 | Russell Investments Group, Ltd. | 1,603 | 0 (0.00%) | 0.00% | $0 M | Nov 6, 2026 |
| 62 | National Bank Of Canada /fi/ | 1,000 | 0 (0.00%) | 0.00% | $0 M | Nov 16, 2026 |
| 63 | BNP Paribas Financial Markets | 662 | 0 (0.00%) | 0.00% | $0 M | Nov 12, 2026 |
| 64 | FMR LLC | 635 | 0 (0.00%) | 0.00% | $0 M | Nov 10, 2026 |
| 65 | Caitong International Asset Management Co., Ltd | 593 | +462 (+352.67%) | 0.00% | $0 M | Oct 29, 2026 |
| 66 | Atlantic Union Bankshares Corp | 425 | -825 (-66.00%) | 0.00% | $0 M | Nov 12, 2026 |
| 67 | Osaic Holdings, Inc. | 380 | 0 (0.00%) | 0.00% | $0 M | Nov 12, 2026 |
| 68 | Nisa Investment Advisors, LLC | 23 | 0 (0.00%) | 0.00% | $0 M | Oct 20, 2026 |
Mutual funds holding Seer, Inc.#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc. | 1.39 M | $2 M | 2.5% | <0.01% | −10.0% | Jun 30, 2026 |
| 🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc. | 377,324 | $1 M | 0.68% | <0.01% | −0.4% | Jun 30, 2026 |
| 🇺🇸 BlackRock Advantage Small Cap Core FundBlackRock Advisors, LLC | 303,882 | $1 M | 0.54% | 0.01% | no change | May 29, 2026 |
| 🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC | 138,567 | $0 M | 0.25% | <0.01% | −0.8% | May 31, 2026 |
| 🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors | 155,254 | $0 M | 0.28% | 0.02% | +39% | Jun 30, 2026 |
| 🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P. | 122,298 | $0 M | 0.22% | <0.01% | +104% | Jun 30, 2026 |
| 🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC | 81,376 | $0 M | 0.15% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC | 66,029 | $0 M | 0.12% | <0.01% | −23% | May 31, 2026 |
| 🇺🇸 Avantis U.S. Small Cap Equity ETFAmerican Century ETF Trust | 61,532 | $0 M | 0.11% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Ultra-Small Company Market FundBridgeway Capital Management, LLC | 66,700 | $0 M | 0.12% | 0.07% | no change | Jun 30, 2026 |
| 🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC | 55,361 | $0 M | 0.10% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 U.S. Micro Cap PortfolioDimensional Fund Advisors LP | 37,826 | $0 M | 0.07% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc. | 34,803 | $0 M | 0.06% | <0.01% | −3.4% | Jun 30, 2026 |
| 🇺🇸 Invesco RAFI US 1500 Small-Mid ETFInvesco Capital Management LLC | 23,735 | $0 M | 0.04% | <0.01% | −10% | Jul 31, 2026 |
| 🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc. | 29,070 | $0 M | 0.05% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Dimensional US Sustainability Core 1 ETFDimensional Fund Advisors LP | 11,353 | $0 M | 0.02% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 U.S. Small Cap PortfolioDimensional Fund Advisors LP | 9,759 | $0 M | 0.02% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC | 10,469 | $0 M | 0.02% | <0.01% | +15% | Jun 30, 2026 |
| 🇺🇸 Dimensional US Vector Equity ETFDimensional Fund Advisors LP | 6,516 | $0 M | 0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 JNL/DFA U.S. Core Equity FundJackson National Asset Management, LLC | 7,945 | $0 M | 0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Avantis U.S. Equity ETFAmerican Century ETF Trust | 6,973 | $0 M | 0.01% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Dimensional U.S. Small Cap ETFDimensional Fund Advisors LP | 5,831 | $0 M | 0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Dimensional US Core Equity 1 ETFDimensional Fund Advisors LP | 5,033 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 JNL/DFA U.S. Small Cap FundJackson National Asset Management, LLC | 6,289 | $0 M | 0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Diversified Equity Alpha Master PortfolioBlackRock Fund Advisors | 5,628 | $0 M | 0.01% | <0.01% | −15% | Jun 30, 2026 |
| 🇺🇸 AST Small-Cap Equity PortfolioAST Investment Services, Inc. | 5,000 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Avantis Total Equity Markets ETFAmerican Century ETF Trust | 4,322 | $0 M | <0.01% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Blackstone Alternative Multi-Strategy FundBlackstone Alternative Investment Advisors LLC | 4,400 | $0 M | <0.01% | <0.01% | −6.4% | Jun 30, 2026 |
| 🇺🇸 LVIP Dimensional U.S. Core Equity 1 FundLincoln Financial Investments Corporation | 3,658 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 LVIP Dimensional U.S. Core Equity 2 FundLincoln Financial Investments Corporation | 2,828 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Avantis U.S. Equity FundAmerican Century ETF Trust | 988 | $0 M | <0.01% | <0.01% | −58% | May 31, 2026 |
| 🇺🇸 Knights of Columbus U.S. ALL CAP INDEX FUNDKnights of Columbus Asset Advisors LLC | 233 | $0 M | <0.01% | <0.01% | +1.3% | Jul 31, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 32 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Insider trading at Seer, Inc.#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Charles EndweissVP Financial Planning Analysis | Grant or award | +35,000 | — | — | 142,641 | Form 4 |
| filed | David R. HornPRESIDENT & CFO | Sell | -7,309 | $2.030 | $15 K | 486,650 | Form 4 |
| filed | Robert LangerDirector | Grant or award | +16,500 | — | — | 821,025 | Form 4 |
| filed | Terrance McGuireDirector | Grant or award | +16,500 | — | — | 128,566 | Form 4 |
| filed | Nicolas H. RoelofsDirector | Grant or award | +16,500 | — | — | 91,496 | Form 4 |
| filed | Meeta GulyaniDirector | Grant or award | +16,500 | — | — | 124,043 | Form 4 |
| filed | Dipchand NisharDirector | Grant or award | +16,500 | — | — | 75,544 | Form 4 |
| filed | Isaac RoDirector | Grant or award | +12,375 | — | — | 53,375 | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals
Markets and events: Seer, Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
Stock splits: 1-for-2.14 reverse split
| Dividend, quarter | Per share | |
|---|---|---|
| Q1 2026 | $0.000 | |
| Q1 2025 | $0.000 | |
| Q1 2024 | $0.000 | |
| Q1 2023 | $0.000 |
| Buybacks, quarter | Fiscal | Spent |
|---|---|---|
| Q4 2024 | Q4 2024 | $0M |
| Q4 2023 | Q4 2023 | $0M |
| Q3 2023 | Q3 2023 | $0M |
| Q2 2023 | Q2 2023 | $0M |
| Q1 2023 | Q1 2023 | $0M |
| Q4 2022 | Q4 2022 | $0M |
| Q3 2022 | Q3 2022 | $0M |
| Q1 2022 | Q1 2022 | $0M |
| Q4 2021 | Q4 2021 | $0M |
| Q3 2021 | Q3 2021 | $0M |
| Q2 2021 | Q2 2021 | $0M |
| Q1 2021 | Q1 2021 | $0M |
| Q4 2020 | Q4 2021 | $0M |
| Q2 2020 | Q2 2021 | $0M |
| Q1 2020 | Q1 2021 | $0M |
Fails to deliver
- : 636 shares at $1.93
- : 14 shares at $1.98
- : 17 shares at $2.02
- : 1,363 shares at $2.16
- : 6 shares at $2.19
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
Seer, Inc. scorecard#
Passes 4 of the 14 checks that could be worked out: strongest in growth (2 of 5), weakest in profitability (1 of 5). Fiscal year 2025; market cap of Aug 1, 2026.
Valuationnot known
- –P/E below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
- –Price to book below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
- –Price to sales below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
- –Free cash flow yield above 5%The market cap dates from 2026-08-01, more than 60 days ago.
- –Earnings yield above the 10-year Treasury yieldThe market cap dates from 2026-08-01, more than 60 days ago.
- –The price assumes slower growth than the last three years'The market cap dates from 2026-08-01, more than 60 days ago.
Growth2 of 5
- ✓Revenue grew in the newest year17.0%Revenue up 17.0% in fiscal 2025.
- ✗Revenue up more than 5% a year over three years2.3%2.3% a year over the three years to fiscal 2025.
- ✗Faster growth over three years than its peers' median2.3%2.3% a year against Biotechnology's median of 12.9% (181 companies).
- –Earnings per share grew in the newest yearEarnings per share of two years are not on file.
- ✗Net income higher than five years earlier-$74 M-$74 M in fiscal 2025 against -$33 M in 2020.
- ✓Revenue rose in at least four of the last five years4 of 5Revenue rose in 4 of the five years to fiscal 2025.
Profitability1 of 5
- ✗Profitable in the newest year-$74 MNet income -$74 M in fiscal 2025.
- ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2025.
- ✗Operating margin above its peers' median-470.4%-470.4% against Biotechnology's median of -60.5% (243 companies).
- ✗Return on equity above 15%-25.1%-25.1% in fiscal 2025.
- –Return on invested capital above 10%No return on invested capital on file.
- ✓Operating margin wider than three years earlier-470.4%-470.4% in fiscal 2025 against -627.8% in 2022.
Financial health1 of 3
- ✓Short-term assets cover short-term liabilities12.8×Current ratio 12.84 at the end of fiscal 2025.
- –Debt below equityDebt or equity is not on file (or equity is negative).
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- –Operating income covers interest five timesInterest expense is not on file.
- ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2025.
- ✗Altman Z-score outside the distress zone-0.39Z-score -0.39 (distress zone) for fiscal 2025.
Shareholder returns0 of 1
- ✗Pays a dividendNoNo dividends in fiscal 2025.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- –Share count up no more than 2% in a yearShare counts of two years are not on file.
- –Dividends and buybacks above 3% of the market valueThe market cap dates from 2026-08-01, more than 60 days ago.
- –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.
Worked out from the statements as filed (sec), the medians of Biotechnology, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Financial analysis, 2025#
Worked out from Seer, Inc.'s statements, beside the median of Biotechnology.
| Ratio | Trend | 2025 | Median of peers |
|---|---|---|---|
| Operating margin | -470.4% | -60.5% | |
| Net margin | -443.9% | -68.9% | |
| Return on equity | -25.1% | -61.0% | |
| Revenue growth, 3 years a year | 2.3% | 12.9% | |
| Revenue growth | 17.0% | 15.8% | |
| Free cash flow margin | -279.0% | -61.5% |
3of 7on the Piotroski tests of financial strength
- Net loss of $74 million, the 6th loss-making year in a row.
- Free cash flow was negative: -$46 million.
Seer, Inc.: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2025to Dec 31, 2025 | FY 2024to Dec 31, 2024 | FY 2023to Dec 31, 2023 | FY 2022to Dec 31, 2022 | FY 2021to Dec 31, 2021 | FY 2020to Dec 31, 2020 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 17+17.0%100% | 14−15.0%100% | 17+7.5%100% | 15+134%100% | 6.6+909%100% | 0.7—100% | |
| Cost of revenue | 8.1+14.0%48.9% | 7.1−12.8%50.2% | 8.2−2.9%48.9% | 8.4+162%54.2% | 3.2—48.4% | 0—0.0% | |
| Gross profit | 8.5+20.0%51.1% | 7.1−17.1%49.8% | 8.5+19.9%51.1% | 7.1+108%45.8% | 3.4+420%51.6% | 0.7—100% | |
| Research and development | 44−13.3%265% | 51−4.6%357% | 53+15.8%318% | 46+57.3%296% | 29+53.7%440% | 19—2888% | |
| Selling, general and administrative | 43−24.7%257% | 57−4.0%399% | 59+0.7%354% | 59+27.9%378% | 46+198%692% | 15—2342% | |
| Operating expenses | 86−19.3%522% | 107−4.3%756% | 112+7.3%672% | 104+39.3%673% | 75+118%1132% | 34—5229% | |
| Operating income | −78—−470% | −100—−706% | −103—−621% | −97—−628% | −71—−1080% | −34—−5129% | |
| Interest and finance income | 12−30.9%69.5% | 17−6.2%118% | 18+286%107% | 4.6+1312%29.7% | 0.3−63.1%4.9% | 0.9—135% | |
| Interest expense and finance costs | — | — | — | 0−100%0.0% | 0.0—0.3% | 0—0.0% | |
| Share of profit of associates | −5.9—−35.7% | −2.6—−18.7% | 0—0.0% | — | — | — | |
| Other non-operating income (expense) | 4.6−66.2%27.7% | 14−20.9%96.0% | 17+303%103% | 4.3+1304%27.6% | 0.3−65.2%4.6% | 0.9—133% | |
| Income before tax | −73—−443% | −87—−610% | −86—−518% | — | — | — | |
| Income tax | 0.2+105%1.2% | 0.1—0.7% | 0—0.0% | 0—0.0% | 0—0.0% | 0—0.0% | |
| Net income including minority interests | — | — | — | −93—−600% | −71—−1076% | −33—−4996% | |
| Net income attributable to shareholders | −74—−444% | −87—−611% | −86—−518% | −93—−600% | −71—−1076% | −33—−4996% | |
| Earnings per share, basic | — | — | -1.35—— | -1.49—— | -1.17—— | -2.48—— | |
| Earnings per share, diluted | — | — | -1.35—— | -1.49—— | -1.17—— | -2.48—— | |
| Shares, weighted average (basic) | — | — | 64+2.3%— | 62+2.6%— | 61+361%— | 13—— | |
| Shares, weighted average (diluted) | — | — | 64+2.3%— | 62+2.6%— | 61+361%— | 13—— | |
| Dividends per share | 0.00—— | 0.00—— | 0.00—— | — | — | — | |
| Balance sheet | |||||||
| Cash and cash equivalents | 47+16.0%16.0% | 41+25.4%11.1% | 32−38.9%7.4% | 53−77.1%10.9% | 233−30.2%43.2% | 334—75.4% | |
| Short-term investments | 139−29.2%46.8% | 196−31.0%53.4% | 284−22.9%65.0% | 368+120%75.4% | 167+70.2%31.0% | 98—22.2% | |
| Receivables | — | — | 4.8+12.0%1.1% | 4.3+72.9%0.9% | 2.5—0.5% | 0—0.0% | |
| Inventory | 7.8+4.8%2.6% | 7.4+65.6%2.0% | 4.5−2.9%1.0% | 4.6+11.6%0.9% | 4.1+652%0.8% | 0.6—0.1% | |
| Current assets | 202−20.4%68.1% | 253−23.4%69.1% | 331−24.0%75.8% | 435+5.7%89.1% | 412−4.9%76.4% | 433—97.9% | |
| Property, plant and equipment | 15−20.6%5.0% | 19−16.3%5.1% | 22+14.3%5.1% | 19+48.3%4.0% | 13+55.0%2.4% | 8.4—1.9% | |
| Right-of-use (leased) assets | 20−10.1%6.9% | 23−9.5%6.2% | 25−6.8%5.8% | 27+34.1%5.5% | 20—3.7% | 0—0.0% | |
| Long-term investments | — | — | — | — | 93—17.3% | — | |
| Total assets | 296−19.2%100% | 367−16.0%100% | 436−10.6%100% | 488−9.5%100% | 539+21.9%100% | 442—100% | |
| Current liabilities | 16+2.4%5.3% | 15+15.9%4.2% | 13+5.1%3.0% | 13−6.3%2.6% | 13+65.8%2.5% | 8.1—1.8% | |
| Lease liabilities (non-current) | 21−10.9%7.1% | 24−8.9%6.5% | 26−7.4%6.0% | 28+24.8%5.7% | 22—4.2% | 0—0.0% | |
| Total liabilities | 37−5.8%12.4% | 39−0.9%10.6% | 39−3.8%9.0% | 41+13.0%8.4% | 36+238%6.7% | 11—2.4% | |
| Retained earnings | −466—−157% | −392—−107% | −306—−70.1% | −219—−45.0% | −127—−23.5% | −55—−12.5% | |
| Shareholders' equity | 259−20.8%87.6% | 328−17.5%89.4% | 397−11.2%91.0% | 447−11.1%91.6% | 503+16.5%93.3% | 432—97.6% | |
| Total liabilities and equity | 296−19.2%100% | 367−16.0%100% | 436−10.6%100% | 488−9.5%100% | 539+21.9%100% | 442—100% | |
| Shares outstanding | — | — | — | 63+2.3%— | 62+4.6%— | 59—— | |
| Cash-flow statement | |||||||
| Depreciation and amortization | 5.1−12.2%30.9% | 5.8+9.0%41.2% | 5.4—32.1% | — | — | — | |
| Share-based compensation | 15−45.4%93.0% | 28−18.1%199% | 34+2.2%207% | 34+29.9%217% | 26+253%392% | 7.3—1120% | |
| Cash from operating activities | −44—−268% | −46—−325% | −59—−355% | −61—−392% | −46—−700% | −21—−3175% | |
| Capital expenditure | −1.8—−10.8% | −3.6—−25.3% | −7.3—−43.9% | −10—−66.3% | −6.9—−105% | −4.5—−691% | |
| Cash from investing activities | 62−6.5%371% | 66+73.7%465% | 38—228% | −123—−792% | −171—−2582% | −35—−5268% | |
| Shares issued | — | — | — | 0−100%0.0% | 103—1556% | 0—0.0% | |
| Shares bought back | — | 0—0.0% | −0.0—−0.1% | −0.0—−0.1% | −0.0—−0.5% | −0.0—−2.0% | |
| Cash from financing activities | −11—−63.7% | −11−2643%−81.1% | 0.5−88.4%2.7% | 3.9−96.7%25.1% | 117−68.6%1763% | 371—56629% | |
| Change in cash | 6.5−20.9%39.4% | 8.3—58.2% | −21—−124% | −180—−1159% | −101−132%−1520% | 316—48186% | |
| Report | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | |
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the same quarter a year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | Last 12 months4 quarters to Sep 30, 2026 | Q3 FY2026to Sep 30, 2026 | Q2 FY2026to Jun 30, 2026 | Q1 FY2026to Mar 31, 2026 | Q4 FY2025to Dec 31, 2025 | Q3 FY2025to Sep 30, 2025 | Q2 FY2025to Jun 30, 2025 | Q1 FY2025to Mar 31, 2025 | Q4 FY2024to Dec 31, 2024 | Q3 FY2024to Sep 30, 2024 | Q2 FY2024to Jun 30, 2024 | Q1 FY2024to Mar 31, 2024 | Q4 FY2023to Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||||||
| Revenue | 14−14.0%100% | 4.0−3.4%100% | 3.1−23.4%100% | 2.8−33.6%100% | 4.2*+5.0%100% | 4.1+2.2%100% | 4.1+31.9%100% | 4.2+37.1%100% | 4.0*−9.9%100% | 4.0—100% | 3.1—100% | 3.1—100% | 4.4*—100% | |
| Cost of revenue | 7.5−6.7%53.5% | 2.1+4.5%52.8% | 1.6−17.7%51.5% | 1.8−15.5%64.8% | 2.0*+2.2%48.0% | 2.0−4.0%48.8% | 1.9+44.7%47.9% | 2.1+25.7%51.0% | 2.0*−19.0%49.4% | 2.1—51.9% | 1.3—43.7% | 1.7—55.6% | 2.4*—54.9% | |
| Gross profit | 6.6−21.2%46.5% | 1.9−10.9%47.2% | 1.5−28.7%48.5% | 1.0−52.4%35.2% | 2.2*+7.8%52.0% | 2.1+8.9%51.2% | 2.1+22.0%52.1% | 2.1+51.4%49.0% | 2.0*+1.2%50.6% | 1.9—48.1% | 1.7—56.3% | 1.4—44.4% | 2.0*—45.1% | |
| Research and development | 33−29.0%236% | 6.4−40.4%162% | 8.2−31.5%265% | 8.8−22.4%315% | 9.7*−22.8%232% | 11−16.7%262% | 12−5.9%296% | 11−7.5%270% | 13*+13.0%315% | 13—322% | 13—415% | 12—400% | 11*—252% | |
| Selling, general and administrative | 40−13.5%281% | 10−5.2%254% | 10−4.9%327% | 9.4−17.6%338% | 9.8*−23.8%234% | 11−19.8%259% | 11−33.8%263% | 11−19.9%272% | 13*−1.3%322% | 13—330% | 16—524% | 14—466% | 13*—294% | |
| Operating expenses | 73−21.3%516% | 17−22.9%416% | 18−19.0%591% | 18−20.0%653% | 20*−23.3%466% | 21−18.3%521% | 23−21.5%559% | 23−14.2%542% | 26*+5.3%638% | 26—651% | 29—938% | 27—866% | 24*—546% | |
| Operating income | −66—−470% | −15—−368% | −17—−543% | −17—−618% | −17*—−414% | −19—−469% | −21—−507% | −21—−493% | −23*—−587% | −24—−603% | −27—−882% | −25—−822% | −22*—−501% | |
| Interest and finance income | 8.8−29.9%62.4% | 2.0−29.1%49.3% | 2.1−31.4%66.2% | 2.2−30.8%79.7% | 2.5*−28.5%60.7% | 2.8−32.3%67.1% | 3.0−32.5%73.9% | 3.2−29.9%76.5% | 3.6*−24.5%89.1% | 4.1—101% | 4.4—144% | 4.6—150% | 4.7*—106% | |
| Share of profit of associates | −6.3—−44.7% | −1.4—−35.0% | −2.1—−67.3% | −1.7—−61.9% | −1.1*—−25.8% | −1.4—−34.4% | −1.8—−45.4% | −1.6—−37.5% | −1.8*—−44.7% | −0.9—−21.4% | 0—0.0% | 0—0.0% | 0*—0.0% | |
| Other non-operating income (expense) | 2.7−45.5%19.4% | 0.9−17.8%23.5% | −0.0−104%−1.6% | 0.4−51.5%15.4% | 1.4*−23.0%33.8% | 1.1−62.1%27.6% | 1.2−72.8%28.5% | 0.9−80.4%21.0% | 1.8*−58.4%46.1% | 3.0—74.3% | 4.2—138% | 4.5—147% | 4.4*—99.9% | |
| Income before tax | −63—−450% | −14—−345% | −17—−544% | −17—−602% | −16*—−380% | −18—−442% | −19—−478% | −20—−472% | −22*—−541% | −21—−529% | −23—−744% | −21—−674% | — | |
| Income tax | 0.1−80.8%0.4% | 0.0−79.2%0.1% | 0.0−81.3%0.3% | 0.0−90.1%0.4% | 0.0*−71.4%0.7% | 0.0—0.6% | 0.0—1.2% | 0.1—2.4% | 0.1*—2.5% | 0—0.0% | 0—0.0% | 0—0.0% | — | |
| Net income attributable to shareholders | −63—−451% | −14—−345% | −17—−545% | −17—−603% | −16*—−381% | −18—−442% | −19—−479% | −20—−474% | −22*—−544% | −21—−529% | −23—−744% | −21—−674% | −18*—−401% | |
| Earnings per share, basic | — | — | — | — | — | — | — | — | — | -0.35—— | -0.35—— | -0.32—— | — | |
| Earnings per share, diluted | — | — | — | — | — | — | — | — | — | -0.35—— | -0.35—— | -0.32—— | — | |
| Shares, weighted average (basic) | — | — | — | — | — | — | — | — | — | 61—— | 65—— | 65—— | — | |
| Shares, weighted average (diluted) | — | — | — | — | — | — | — | — | — | 61—— | 65—— | 65—— | — | |
| Dividends per share | — | — | — | 0.00—— | — | — | — | 0.00—— | — | — | — | 0.00—— | — | |
| Balance sheet | ||||||||||||||
| Cash and cash equivalents | 29—12.1% | 29−34.8%12.1% | 26−31.3%10.2% | 47−9.8%17.4% | 47+16.0%16.0% | 45+19.5%14.6% | 38+18.7%11.8% | 52−3.6%15.1% | 41+25.4%11.1% | 38—9.8% | 32—7.9% | 54—12.9% | 32—7.4% | |
| Short-term investments | 127—52.3% | 127−17.9%52.3% | 127−26.2%49.4% | 119−36.3%43.9% | 139−29.2%46.8% | 154−26.5%50.0% | 172−31.7%53.3% | 187−26.3%53.9% | 196−31.0%53.4% | 210—54.8% | 252—61.9% | 254—60.2% | 284—65.0% | |
| Receivables | — | — | — | — | — | — | — | — | — | — | — | — | 4.8—1.1% | |
| Inventory | 6.4—2.6% | 6.4−21.3%2.6% | 7.7+2.0%3.0% | 8.1+14.3%3.0% | 7.8+4.8%2.6% | 8.1+17.2%2.6% | 7.5−0.9%2.3% | 7.1+21.7%2.0% | 7.4+65.6%2.0% | 6.9—1.8% | 7.6—1.9% | 5.8—1.4% | 4.5—1.0% | |
| Current assets | 168—69.4% | 168−21.7%69.4% | 166−26.4%64.7% | 182−28.9%66.7% | 202−20.4%68.1% | 214−18.8%69.5% | 226−24.7%70.0% | 255−21.3%73.5% | 253−23.4%69.1% | 264—68.9% | 300—73.7% | 324—76.8% | 331—75.8% | |
| Property, plant and equipment | 11—4.6% | 11−28.7%4.6% | 12−26.2%4.7% | 13−20.9%5.0% | 15−20.6%5.0% | 15−25.2%5.0% | 16−19.3%5.1% | 17−19.5%4.9% | 19−16.3%5.1% | 21—5.4% | 20—5.0% | 21—5.0% | 22—5.1% | |
| Right-of-use (leased) assets | 19—7.7% | 19−11.5%7.7% | 19−11.0%7.5% | 20−10.5%7.3% | 20−10.1%6.9% | 21−9.7%6.8% | 22−9.6%6.7% | 22−9.5%6.4% | 23−9.5%6.2% | 23—6.1% | 24—5.9% | 25—5.8% | 25—5.8% | |
| Total assets | 242—100% | 242−21.6%100% | 257−20.4%100% | 272−21.6%100% | 296−19.2%100% | 309−19.5%100% | 322−20.7%100% | 347−17.7%100% | 367−16.0%100% | 383—100% | 407—100% | 422—100% | 436—100% | |
| Current liabilities | 9.9—4.1% | 9.9−33.9%4.1% | 11−4.4%4.4% | 10−22.4%3.8% | 16+2.4%5.3% | 15+4.6%4.9% | 12−30.8%3.7% | 13+2.9%3.8% | 15+15.9%4.2% | 14—3.8% | 17—4.2% | 13—3.0% | 13—3.0% | |
| Lease liabilities (non-current) | 19—7.8% | 19−12.8%7.8% | 20−12.1%7.7% | 20−11.5%7.5% | 21−10.9%7.1% | 22−10.3%7.0% | 22−9.8%6.9% | 23−9.4%6.6% | 24−8.9%6.5% | 24—6.3% | 25—6.1% | 25—6.0% | 26—6.0% | |
| Total liabilities | 29—12.0% | 29−21.4%12.0% | 31−9.5%12.1% | 31−15.5%11.3% | 37−5.8%12.4% | 37−4.9%11.9% | 34−18.4%10.6% | 36−5.6%10.4% | 39−0.9%10.6% | 39—10.1% | 42—10.3% | 38—9.1% | 39—9.0% | |
| Retained earnings | −513—−212% | −513—−212% | −500—−195% | −483—−177% | −466—−157% | −450—−146% | −432—−134% | −412—−119% | −392—−107% | −371—−96.7% | −349—−85.9% | −326—−77.4% | −306—−70.1% | |
| Shareholders' equity | 213—88.0% | 213−21.7%88.0% | 226−21.7%87.9% | 241−22.4%88.7% | 259−20.8%87.6% | 272−21.2%88.1% | 288−21.0%89.4% | 311−18.9%89.6% | 328−17.5%89.4% | 345—89.9% | 365—89.7% | 384—90.9% | 397—91.0% | |
| Total liabilities and equity | 242—100% | 242−21.6%100% | 257−20.4%100% | 272−21.6%100% | 296−19.2%100% | 309−19.5%100% | 322−20.7%100% | 347−17.7%100% | 367−16.0%100% | 383—100% | 407—100% | 422—100% | 436—100% | |
| Cash-flow statement | ||||||||||||||
| Depreciation and amortization | 4.5−17.8%31.7% | 1.0−15.6%25.6% | 1.1−15.7%36.0% | 1.2−18.7%41.5% | 1.2*−20.7%27.7% | 1.2−18.1%29.3% | 1.3−9.0%32.8% | 1.4−0.8%33.9% | 1.5*—36.6% | 1.5—36.6% | 1.5—47.5% | 1.4—46.8% | — | |
| Share-based compensation | 8.2−55.9%58.2% | 1.2−66.1%30.6% | 1.6−59.6%50.4% | 2.1−54.4%76.2% | 3.3*−49.0%78.2% | 3.6−44.9%87.2% | 3.9−49.5%95.6% | 4.7−38.5%111% | 6.4*−15.4%161% | 6.5—162% | 7.7—250% | 7.6—247% | 7.6*—172% | |
| Cash from operating activities | −45—−322% | −9.5*—−239% | −9.6*—−309% | −15—−553% | −11*—−257% | −7.6*—−184% | −15*—−362% | −11—−272% | −11*—−286% | −14*—−350% | −10*—−328% | −10—−341% | −10*—−230% | |
| Capital expenditure | −1.0—−7.2% | −0.4*—−11.0% | −0.0*—−0.3% | −0.3—−9.7% | −0.3*—−7.0% | −0.3*—−6.9% | −0.6*—−14.0% | −0.7—−15.6% | — | −2.2*—−54.4% | −1.2*—−38.2% | −0.8—−24.6% | −1.8*—−41.4% | |
| Cash from investing activities | 32−50.0%229% | 13*−23.8%318% | −11*−256%−370% | 18−26.6%647% | 13*−18.1%309% | 17*−37.2%403% | 7.4*—182% | 25−23.9%585% | 16*+159%396% | 26*—656% | −8.8*—−286% | 32—1055% | 6.1*—138% | |
| Shares bought back | — | — | — | — | — | — | — | — | 0*—0.0% | — | — | — | 0*—0.0% | |
| Cash from financing activities | −2.5—−18.1% | 0.1*—3.2% | −0.2*—−6.6% | −2.6—−93.4% | 0.1*—3.4% | −2.0*—−48.3% | −7.2*—−178% | −1.5—−35.7% | −1.3*−791%−31.4% | −6.6*—−165% | −3.6*—−117% | 0—0.0% | 0.2*—4.1% | |
| Change in cash | −16−313%−111% | 3.2*−54.0%81.4% | −21*—−685% | 0.0−99.7%1.2% | 2.3*−26.2%55.0% | 7.0*+24.1%171% | −15*—−358% | 12−46.6%278% | 3.1*—78.3% | 5.7*—141% | −22*—−731% | 22—714% | −3.9*—−87.8% | |
| Report | Worked out | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | |
* Worked out from reported figures: a quarter the company states only within a year-to-date figure (cash flows are reported that way), or the fourth quarter as the fiscal year minus the first nine months.
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
Executive pay at Seer, Inc.#
From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.
| Fiscal year | CEO total pay | Actually paid | Other executives, average | $100 invested |
|---|---|---|---|---|
| 2024Omid Farokhzad | $3.5 M | $4.6 M | $1.1 M | $10 |
| 2023Omid Farokhzad | $5.2 M | −$137 K | $1.4 M | $9 |
| 2022Omid Farokhzad | $6.7 M | −$15.5 M | $3.9 M | $25 |
Source: SEC proxy statement (Form DEF 14A) · as of Dec 31, 2024
Events at Seer, Inc.#
What the company reported to the SEC within four business days (Form 8-K), newest first.
Warning signs in the last three years
- Delisting noticeFiling
Delisting notice 1 · Directors and officers 4 · Material agreement 2 · Shareholder rights changed 3 · Bylaws or fiscal year changed 2 · Shareholder vote 2 · Results announced 9
| Filed | What happened | Filing |
|---|---|---|
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Results announced | 8-K | |
| Shareholder vote | 8-K | |
| Results announced | 8-K | |
| Material agreementShareholder rights changed | 8-K | |
| Results announced | 8-K | |
| Material agreementShareholder rights changedBylaws or fiscal year changed | 8-K | |
| Shareholder rights changedBylaws or fiscal year changed | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Results announced | 8-K | |
| Delisting noticeShareholder vote | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Directors and officers | 8-K |
Source: SEC EDGAR, Form 8-K item numbers · as of Nov 10, 2026
Acquisitions and funding#
1 private funding rounds before listing
Private share sales · funding history
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Dec 2017 | $6 M | No. 1 | $2 to $10 million | 11 | equity | SEC |
Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.
H-1B hiring at Seer, Inc.#
2 labor condition applications certified in fiscal 2026 for 2 positions, at a median wage of $137 K a year.
| Job title | Positions | Median wage offered |
|---|---|---|
| Scientist IIChemists | 1 | $148 K |
| Sr. Research AssociateMedical Scientists, Except Epidemiologists | 1 | $125 K |
Where: Redwood City, CA 2
| Fiscal year | Certified | Positions | Median wage | Filed |
|---|---|---|---|---|
| FY2026 | 2 | 2 | $137 K | 2 |
| FY2025 | 3 | 3 | $156 K | 4 |
| FY2024 | 3 | 3 | $175 K | 3 |
| FY2023 | 6 | 6 | $140 K | 6 |
| FY2022 | 2 | 2 | $150 K | 2 |
| FY2021 | 5 | 5 | $121 K | 5 |
| FY2020 | 2 | 2 | $64 K | 3 |
Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Seer, Inc.
How Seer, Inc. compares in Biotechnology
- Market cap$115 M · higher than 38% of 726
- Revenue$17 M · higher than 48% of 647
- Net margin-450.9% · higher than 14% of 408
- Revenue growth17.0% · higher than 59% of 438
- Price / sales8.2× · lower than 49% of 339
- Price / book0.4× · lower than 94% of 534
- FCF yield-40.2% · higher than 29% of 449
Peer comparison · Biotechnology
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Seer, Inc.🇺🇸 | $115 M | — | -450.9% | +17.0% |
| Novo Nordisk A/S🇩🇰 | $203.2 B | 13.1× | 33.1% | +10.8% |
| Vertex Pharmaceuticals Incorporated🇺🇸 | $134.3 B | 33.8× | 30.7% | +8.9% |
| Moderna, Inc.🇺🇸 | $90.1 B | — | -110.5% | -39.9% |
| Regeneron Pharmaceuticals, Inc.🇺🇸 | $84.1 B | 17.5× | 28.5% | +1.0% |
| Argenx SE🇳🇱 | $52.8 B | 40.9× | 31.1% | +89.9% |
| CSL Limited🇦🇺 | $51.6 B | — | -16.4% | — |
| Samsung Biologics Co., Ltd.🇰🇷 | $51.5 B | 40.5× | 39.2% | — |
| UCB SA🇧🇪 | $48.6 B | 26.3× | 20.1% | +31.1% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Regenxbio Inc.$513 M
- Pharmicell Co., Ltd.$514 M
- Pulike Biological Engineering, Inc.$524 M
- Contineum Therapeutics, Inc.$534 M
- Entera Bio Ltd.$543 M
- Arvinas, Inc.$544 M
Sources and freshness
- Market cap:
- Aug 1, 2026
- Annual results:
- For year ending December-2025
- Balance sheet:
- As of December-2025
- Employees:
- As on 2019
- Profile updated:
- Nov 20, 2026
Figures from Market data, SEC filing, value.today research, Wikidata; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Seer, Inc.? Verify and update this profile — free
Show Seer, Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.